TMF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.708800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.674800E-01
Normal-vs-Stage2
8.995000E-01
Normal-vs-Stage3
9.488500E-02
Normal-vs-Stage4
2.546800E-01
Stage1-vs-Stage2
8.074400E-01
Stage1-vs-Stage3
1.449420E-01
Stage1-vs-Stage4
2.926400E-01
Stage2-vs-Stage3
1.062230E-01
Stage2-vs-Stage4
1.161980E-01
Stage3-vs-Stage4
1.360190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.331800E-01
Normal-vs-AfricanAmerican
8.450600E-01
Normal-vs-Asian
9.227800E-01
Caucasian-vs-AfricanAmerican
4.975600E-01
Caucasian-vs-Asian
8.948800E-01
AfricanAmerican-vs-Asian
7.203800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.482000E-01
Normal-vs-Female
9.077000E-01
Male-vs-Female
7.608800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.939400E-01
Normal-vs-Age(41-60Yrs)
6.655000E-01
Normal-vs-Age(61-80Yrs)
6.426000E-01
Normal-vs-Age(81-100Yrs)
3.412000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.839200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.039400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.254400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.403700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.712490E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.992200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.556800E-01
Normal-vs-Daily Drinker
2.954800E-01
Normal-vs-Weekly Drinker
6.372000E-01
Normal-vs-Occasional Drinker
8.170800E-01
Normal-vs-Social Drinker
8.812000E-01
Non Drinker-vs-Daily Drinker
2.413800E-01
Non Drinker-vs-Weekly Drinker
9.497400E-01
Non Drinker-vs-Occasional Drinker
1.918200E-01
Non Drinker-vs-Social Drinker
2.717200E-01
Daily Drinker-vs-Weekly Drinker
3.517400E-01
Daily Drinker-vs-Occasional Drinker
3.965600E-02
Daily Drinker-vs-Social Drinker
5.054300E-02
Weekly Drinker-vs-Occasional Drinker
2.806400E-01
Weekly Drinker-vs-Social Drinker
3.350400E-01
Occasional Drinker-vs-Social Drinker
8.476200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.339850E-01
Normal-vs-Grade 2
4.277700E-02
Normal-vs-Grade 3
3.504100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.836200E-01
Grade 1-vs-Grade 3
2.740200E-01
Grade 1-vs-Grade 4
1.339850E-01
Grade 2-vs-Grade 3
8.687400E-01
Grade 2-vs-Grade 4
4.277700E-02
Grade 3-vs-Grade 4
3.504100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.927400E-01
Normal-vs-NonDiabetic
7.759200E-01
Diabetic-vs-NonDiabetic
4.418400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.254800E-01
Normal-vs-NoPancreatitis
7.678800E-01
Pancreatitis-vs-NoPancreatitis
8.294600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.461400E-01
Normal-vs-N1
8.615200E-01
N0-vs-N1
7.697000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.483600E-01
Normal-vs-TP53-NonMutant
9.865600E-01
TP53-Mutant-vs-TP53-NonMutant
7.842600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
